Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Author:

Foley John F,Defer Gilles,Ryerson Lana Zhovtis,Cohen Jeffrey A,Arnold Douglas L,Butzkueven Helmut,Cutter Gary,Giovannoni Gavin,Killestein Joep,Wiendl Heinz,Smirnakis Karen,Xiao Shan,Kong George,Kuhelj Robert,Campbell Nolan,van der Walt Anneke,Dwyer Christopher,Buzzard Katherine,Spies Judith,Parratt John,van Pesch Vincent,Willekens Barbara,Perrotta Gaetano,Bartholomé Emmanuel,Grand'Maison Francois,Jacques Francois,Giacomini Paul,Vosoughi Reza,Girard Jean-Marc,de Seze Jerome,Lebrun Frenay Christine,Ruet Aurelie,Laplaud David-Axel,Reifschneider Gerd,Wagner Bert,Rauer Sebastian,Pul Refik,Seipelt Maria,Berthele Achim,Klotz Luisa,Kallmann Boris-Alexander,Paul Friedemann,Achiron Anat,Lus Giacomo,Centonze Diego,Patti Francesco,Grimaldi Luigi,Hupperts Raymond,Frequin Stephan,Fermont Jiske,Madueno Sara Eichau,Alonso Torres Ana Maria,Costa-Frossard França Lucienne,Meca-Lallana Jose Eustasio,Ruiz Luis Brieva,Pearson Owen,Rog David,Evangelou Nikolaos,Ismail Azza,Lathi Ellen,Fox Edward,Leist Thomas,Sloane Jacob,Wu Gregory,Khatri Bhupendra,Steingo Brian,Thrower Ben,Gudesblatt Mark,Calkwood Jonathan,Bandari Daniel,Scagnelli John,Laganke Christopher,Robertson Derrick,Kipp Lucas,Belkin Martin,Cohan Stanley,Goldstick Lawrence,Courtney Ardith,Vargas Wendy,Sylvester Andrew,Srinivasan Jayshri,Kannan Meena,Picone Maryann,English Jeffrey,Napoli Salvatore,Balabanov Roumen,Zaydan Islam,Nicholas Jacqueline,Kaplan Jeffrey,Lublin Fred,Riser Emily,Miller Tamara,Alvarez Enrique,Wray Sibyl,Gross Jeffrey,Pawate Siddharama,Hersh Carrie,McCarthy Lucas,Crayton Heidi,Graves Jennifer

Funder

Biogen

Publisher

Elsevier BV

Subject

Neurology (clinical)

Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3